Publication:
Cutaneous Leukocytoclastic Vasculitis Associated With Anti-Tuberculosis Drugs

dc.authorscopusid56088300100
dc.authorscopusid32467523200
dc.authorscopusid55979401400
dc.authorscopusid6603029522
dc.authorscopusid22934849400
dc.authorscopusid55420432800
dc.authorscopusid55420432800
dc.contributor.authorAvcu, G.
dc.contributor.authorŞensoy, S.G.
dc.contributor.authorÇeli̇Ksoy, M.H.
dc.contributor.authorSöǧüt, A.
dc.contributor.authorKefeli, M.
dc.contributor.authorKarlı, A.
dc.contributor.authorBelet, Nursen
dc.date.accessioned2020-06-21T13:50:57Z
dc.date.available2020-06-21T13:50:57Z
dc.date.issued2015
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Avcu] Gülhadiye, Department of Pediatric Infectious Diseases, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Şensoy] Gülnar, Department of Pediatric Infectious Diseases, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Çeli̇Ksoy] Mehmet Halil, Department of Pediatric Allergy and Immunology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Söǧüt] Ayhan, Department of Pediatric Allergy and Immunology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Kefeli] Mehmet, Department of Pathology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Karlı] Arzu, Department of Pediatric Infectious Diseases, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Belet] Nurşen M., Department of Pediatric Infectious Diseases, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractLeukocytoclastic vasculitis (LCV), a disease characterized by inflammation of the small vessels, presents with palpable purpura, especially in the lower extremities. Its etiology is known to include drugs, infection, collagen tissue disease, and malignancy, but LCV caused by anti-tuberculosis drugs is very rarely seen. This report describes the case of a 12-year-old girl who developed LCV with rifampicin and ethambutol while undergoing anti-tuberculosis treatment due to extensive pulmonary involvement. © 2015 Japan Pediatric Society.en_US
dc.identifier.doi10.1111/ped.12403
dc.identifier.endpage157en_US
dc.identifier.issn1328-8067
dc.identifier.issue1en_US
dc.identifier.pmid25711253
dc.identifier.scopus2-s2.0-84923353264
dc.identifier.scopusqualityQ3
dc.identifier.startpage155en_US
dc.identifier.urihttps://doi.org/10.1111/ped.12403
dc.identifier.urihttps://hdl.handle.net/20.500.12712/14519
dc.identifier.volume57en_US
dc.identifier.wosWOS:000350346800030
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.ispartofPediatrics Internationalen_US
dc.relation.journalPediatrics Internationalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnti-Tuberculosis Drugen_US
dc.subjectEthambutolen_US
dc.subjectLeukocytoclastic Vasculitisen_US
dc.subjectRifampicinen_US
dc.titleCutaneous Leukocytoclastic Vasculitis Associated With Anti-Tuberculosis Drugsen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files